Health-related quality of life in patients with iron deficiency anemia: impact of treatment with intravenous iron

References

• World Health OrganizationIron deficiency anaemia: assessment, prevention and controlGenevaWorld Health Organization2001 Available from: http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/WHO_NHD_01.3/en/Accessed August 3, 2018
   Google Scholar
• WeissGGoodnoughLTAnemia of chronic diseaseN Engl J Med2005352101011102315758012
   PubMed Web of Science ®Google Scholar
• MacdougallICQuality of life and anemia: the nephrology experienceSemin Oncol1998253 Suppl 73942
   Web of Science ®Google Scholar
• MacdougallICLewisNPSaundersMJLong-term cardiorespiratory effects of amelioration of renal anaemia by erythropoietinLancet199033586884894931968526
   PubMed Web of Science ®Google Scholar
• SobreroAPuglisiFGuglielmiAFatigue: a main component of anemia symptomatologySemin Oncol2001282 Suppl 81518
   PubMed Web of Science ®Google Scholar
• AaronsonLSTeelCSCassmeyerVDefining and measuring fatigueImage J Nurs Sch1999311455010081212
   PubMedGoogle Scholar
• CellaDThe Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: a new tool for the assessment of outcomes in cancer anemia and fatigueSemin Hematol1997343 Suppl 21319
   PubMed Web of Science ®Google Scholar
• YellenSBCellaDFWebsterKBlendowskiCKaplanEMeasuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement systemJ Pain Symptom Manage199713263749095563
   PubMed Web of Science ®Google Scholar
• CrawfordJCellaDCleelandCSRelationship between changes in hemoglobin level and quality of life during chemotherapy in anemic cancer patients receiving epoetin alfa therapyCancer200295488889512209734
   PubMed Web of Science ®Google Scholar
• DemetriGDKrisMWadeJDegosLCellaDQuality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: results from a prospective community oncology study. Procrit Study GroupJ Clin Oncol19981610341234259779721
   PubMed Web of Science ®Google Scholar
• GlaspyJBukowskiRSteinbergDTaylorCTchekmedyianSVadhan-RajSImpact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study GroupJ Clin Oncol1997153121812349060566
   PubMed Web of Science ®Google Scholar
• QuirtIRobesonCLauCYEpoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapyJ Clin Oncol200119214126413411689580
   PubMed Web of Science ®Google Scholar
• Vadhan-RajSMirtschingBCharuVAssessment of hematologic effects and fatigue in cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeksJ Support Oncol20031213113815352656
   PubMedGoogle Scholar
• AlexanderMKewalramaniRAgodoaIGlobeDAssociation of anemia correction with health related quality of life in patients not on dialysisCurr Med Res Opin200723122997300817958944
   PubMed Web of Science ®Google Scholar
• ConlonNPBaleEPHerbisonGPMccarrollMPostoperative anemia and quality of life after primary hip arthroplasty in patients over 65 years oldAnesth Analg200810641056106118349173
   PubMed Web of Science ®Google Scholar
• AcasterSDickerhoofRDebuskKBernardKStraussWAllenLFQualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemiaHealth Qual Life Outcomes2015136025980742
   PubMed Web of Science ®Google Scholar
• WareJEKosinskiMBjornerJBTurner-BowkerDMGandekBMaruishMEUser’s Manual for the SF-36v2Health SurveyQuality-Metric Incorporated2007
   Google Scholar
• McHorneyCAWareJERogersWRaczekAELuJFJrLThe validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes StudyMed Care1992305 SupplMS253-65MS253-MS2651583937
   PubMed Web of Science ®Google Scholar
• TheinMErshlerWBArtzASDiminished quality of life and physical function in community-dwelling elderly with anemiaMedicine200988210711419282701
   PubMed Web of Science ®Google Scholar
• WolfeFHawleyDJWilsonKThe prevalence and meaning of fatigue in rheumatic diseaseJ Rheumatol1996238140714178856621
   PubMed Web of Science ®Google Scholar
• BrazierJRobertsJDeverillMThe estimation of a preference-based measure of health from the SF-36J Health Econ200221227129211939242
   PubMed Web of Science ®Google Scholar
• WaltersSJBrazierJEComparison of the minimally important difference for two health state utility measures: EQ-5D and SF-6DQual Life Res20051461523153216110932
   PubMed Web of Science ®Google Scholar
• FrybackDGDunhamNCPaltaMUS norms for six generic health-related quality-of-life indexes from the National Health Measurement studyMed Care200745121162117018007166
   PubMed Web of Science ®Google Scholar
• AuerbachMBallardHTroutJRIntravenous iron optimizes the response to recombinant human erythropoietin in cancer patients with chemotherapy-related anemia: a multicenter, open-label, randomized trialJ Clin Oncol20042271301130715051778
   PubMed Web of Science ®Google Scholar
• HenryDHAbelsRIRecombinant human erythropoietin in the treatment of cancer and chemotherapy-induced anemia: results of double-blind and open-label follow-up studiesSemin Oncol1994212 Suppl 32128
   Web of Science ®Google Scholar
• FinkelsteinFOStoryKFiranekCHealth-related quality of life and hemoglobin levels in chronic kidney disease patientsClin J Am Soc Nephrol200941333818987300
   PubMed Web of Science ®Google Scholar
• JaeschkeRSingerJGuyattGHMeasurement of health status. Ascertaining the minimal clinically important differenceControl Clin Trials19891044074152691207
   PubMedGoogle Scholar
• LeafDEGoldfarbDSInterpretation and review of health-related quality of life data in CKD patients receiving treatment for anemiaKidney Int2009751152418813284
   PubMed Web of Science ®Google Scholar
• NormanGRSloanJAWyrwichKWInterpretation of changes in health-related quality of life: the remarkable universality of half a standard deviationMed Care200341558259212719681
   PubMed Web of Science ®Google Scholar
• CellaDEtonDTLaiJSPetermanAHMerkelDECombining anchor and distribution-based methods to derive minimal clinically important differences on the Functional Assessment of Cancer Therapy (FACT) anemia and fatigue scalesJ Pain Symptom Manage200224654756112551804
   PubMed Web of Science ®Google Scholar
• BjornerJBWallensteinGVMartinMCInterpreting score differences in the SF-36 vitality scale: using clinical conditions and functional outcomes to define the minimally important differenceCurr Med Res Opin200723473173917407629
   PubMed Web of Science ®Google Scholar
• JonesMSchenkelBJustJFallowfieldLEpoetin alfa improves quality of life in patients with cancer: results of metaanalysisCancer200410181720173215386341
   PubMed Web of Science ®Google Scholar
• CellaDKallichJMcdermottAXuXThe longitudinal relationship of hemoglobin, fatigue and quality of life in anemic cancer patients: results from five randomized clinical trialsAnn Oncol200415697998615151958
   PubMed Web of Science ®Google Scholar
• Vadhan-RajSStraussWFordDEfficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral ironAm J Hematol201489171223983177
   PubMed Web of Science ®Google Scholar
• PatrickDLGagnonDDZagariMJMathijsRSweetenhamJEpoetin Alfa Study GroupAssessing the clinical significance of health-related quality of life (HrQOL) improvements in anaemic cancer patients receiving epoetin alfaEur J Cancer200339333534512565986
   PubMed Web of Science ®Google Scholar
• LittlewoodTJBajettaENortierJWVercammenERapoportBEpoetin Alfa Study GroupEffects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trialJ Clin Oncol200119112865287411387359
   PubMed Web of Science ®Google Scholar
• DammaccoFCastoldiGRödjerSEfficacy of epoetin alfa in the treatment of anaemia of multiple myelomaBr J Haematol2001113117217911328297
   PubMed Web of Science ®Google Scholar
• AndoKMoritaSHigashiTHealth-related quality of life among Japanese women with iron-deficiency anemiaQual Life Res200615101559156316826432
   PubMed Web of Science ®Google Scholar
• MakridesMCrowtherCAGibsonRAGibsonRSSkeaffCMEfficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trialAm J Clin Nutr200378114515312816784
   PubMed Web of Science ®Google Scholar
• MacdougallICStrategies for iron supplementation: oral versus intravenousKidney Int Suppl199969S61S6610084288
   PubMed Web of Science ®Google Scholar
• KaltwasserJPKesslerUGottschalkRStuckiGMöllerBEffect of recombinant human erythropoietin and intravenous iron on anemia and disease activity in rheumatoid arthritisJ Rheumatol200128112430243611708414
   PubMed Web of Science ®Google Scholar
• AnthonyLBGabrailNYGhazalHIV iron sucrose for cancer and/or chemotherapy-induced anemia in patients treated with erythropoiesis-stimulating agentsCommunity Oncol201186270278
   Google Scholar
• HenryDHDahlNVAuerbachMTchekmedyianSLaufmanLRIntravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapyOncologist200712223124217296819
   PubMed Web of Science ®Google Scholar
• HenryDHDahlNVThe Ferrlecit Cancer Study GroupDoes quality of life improvement precede anemia correction in patients with chemotherapy-induced anemia treated with intravenous iron? [abstract]J Clin Oncol20072518 Suppl90829082
   Web of Science ®Google Scholar
• van WyckDBMangioneAMorrisonJHadleyPEJehleJAGoodnoughLTLarge-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trialTransfusion200949122719272819682342
   PubMed Web of Science ®Google Scholar
• HetzelDStraussWBernardKLiZUrbonieneAAllenLFA Phase III, randomized, open-label trial of ferumoxytol compared with iron sucrose for the treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapyAm J Hematol201489664665024639149
   PubMed Web of Science ®Google Scholar
• StraussWDahlNVadhan-RajSEffects of IV iron treatment with ferumoxytol on health-related quality of life of patients with iron deficiency anemiaJ Community Support Oncol2016148342350
   Google Scholar
• HaasJDBrownlieTIron deficiency and reduced work capacity: a critical review of the research to determine a causal relationshipJ Nutr20011312S-2676S69011160598
   PubMed Web of Science ®Google Scholar
• VerdonFBurnandBStubiCLIron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trialBMJ20033267399112412763985
   PubMed Web of Science ®Google Scholar
• AnkerSDComin ColetJFilippatosGFerric carboxymaltose in patients with heart failure and iron deficiencyN Engl J Med2009361252436244819920054
   PubMed Web of Science ®Google Scholar
• PonikowskiPvan VeldhuisenDJComin-ColetJBeneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiencyEur Heart J2015361165766825176939
   PubMed Web of Science ®Google Scholar